Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 71, 209249 (2021).

Article Google Scholar

Thrift, A. P. & El-Serag, H. B. Burden of gastric cancer. Clin. Gastroenterol. Hepatol. 18, 534542 (2020).

PubMed Article Google Scholar

Zhang, X. et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: A meta-analysis and systematic review. Gastroenterology 155, 347354 (2018).

PubMed Article Google Scholar

Huang, H. L. et al. Effect and cost-effectiveness of national gastric cancer screening in Japan: A microsimulation modeling study. BMC Med. 18, 257 (2020).

PubMed PubMed Central Article Google Scholar

Arnold, M. et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 69, 823829 (2020).

PubMed Article Google Scholar

Ferlay, J. et al. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer (2020). https://gco.iarc.fr/tomorrow. Accessed 18 Nov 2021.

Lobo, R. A. Hormone-replacement therapy: Current thinking. Nat. Rev. Endocrinol. 13, 220231 (2017).

CAS PubMed Article Google Scholar

Wells, G. et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocrine Rev. 23, 529539 (2002).

CAS Article Google Scholar

Collaborative Group on Epidemiological Studies of Ovarian Cancer. Menopausal hormone use and ovarian cancer risk: Individual participant meta-analysis of 52 epidemiological studies. Lancet 385, 18351842 (2015).

PubMed Central Article CAS Google Scholar

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: Individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 394, 11591168 (2019).

PubMed Central Article Google Scholar

Lagergren, K., Lagergren, J. & Brusselaers, N. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: A systematic review and meta-analysis. Int. J. Cancer 135, 21832190 (2014).

CAS PubMed Article Google Scholar

Johnson, J. R. et al. Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol. Biomark. Prev. 18, 196203 (2009).

CAS Article Google Scholar

Jang, Y. C., Huang, H. L. & Leung, C. Y. Association of hormone replacement therapy with mortality in colorectal cancer survivor: A systematic review and meta-analysis. BMC Cancer 19, 1199 (2019).

CAS PubMed PubMed Central Article Google Scholar

Chlebowski, R. T. et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N. Engl. J. Med. 350, 9911004 (2004).

CAS PubMed Article Google Scholar

Grodstein, F., Newcomb, P. A. & Stampfer, M. J. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am. J. Med. 106, 574582 (1999).

CAS PubMed Article Google Scholar

Camargo, M. C. et al. Sex hormones, hormonal interventions, and gastric cancer risk: A meta-analysis. Cancer Epidemiol. Biomark. Prev. 21, 2038 (2012).

CAS Article Google Scholar

Brusselaers, N., Maret-Ouda, J., Konings, P., El-Serag, H. B. & Lagergren, J. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int. J. Cancer 140, 16931699 (2017).

CAS PubMed Article Google Scholar

Wang, Z. et al. Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study. Int. J. Cancer 138, 28372845 (2016).

CAS PubMed PubMed Central Article Google Scholar

Lope, V. et al. Menstrual and reproductive factors and risk of gastric and colorectal cancer in Spain. PLoSOne 11, e0164620 (2016).

PubMed PubMed Central Article CAS Google Scholar

Wells, G., Shea, B., & OConnell, D. Proceedings of the Third Symposium on Systematic Reviews. Beyond the Basics: Improving Quality and Impact. Oxford: The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analysis. (2000).

Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 15391558 (2002).

PubMed Article Google Scholar

IntHout, J., Ioannidis, J. P., Rovers, M. M. & Goeman, J. J. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6, e010247 (2016).

PubMed PubMed Central Article Google Scholar

Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629634 (1997).

CAS PubMed PubMed Central Article Google Scholar

Duval, S. & Tweedie, R. Trim and fill: A simple funnel-plot- based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455463 (2000).

CAS PubMed MATH Article Google Scholar

Patsopoulos, N. A., Evangelou, E. & Ioannidis, J. P. Sensitivity of between-study heterogeneity in meta-analysis: Proposed metrics and empirical evaluation. Int. J. Epidemiol. 37, 11481157 (2008).

PubMed PubMed Central Article Google Scholar

Kaneko, S., Tamakoshi, A., Ohno, Y., Mizoue, T. & Yoshimura, T. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control 14, 5359 (2003).

PubMed Article Google Scholar

La Vecchia, C. et al. Menstrual and reproductive factors and gastric-cancer risk in women. Int. J. Cancer 59, 761764 (1994).

PubMed Article Google Scholar

Lindblad, M., Rodriguez, L. G., Chandanos, E. & Lagergren, J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br. J. Cancer 94, 136141 (2006).

CAS PubMed Article Google Scholar

Duell, E. J. et al. Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition. Am. J. Epidemiol. 172, 13841393 (2010).

PubMed Article Google Scholar

Freedman, N. D. et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer Interdiscip. Int. J. Am. Cancer Soc. 116, 15721581 (2010).

Google Scholar

Freedman, N. D. et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut 56, 16711677 (2007).

PubMed PubMed Central Article Google Scholar

Nam, J. H. et al. The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: A population-based cohort study. BMC Gastroenterol. 21, 12 (2021).

Article CAS Google Scholar

Green, J. et al. Menopausal hormone therapy and risk of gastrointestinal cancer: Nested casecontrol study within a prospective cohort, and meta-analysis. Int. J. Cancer 130, 23872396 (2012).

CAS PubMed Article Google Scholar

Frise, S., Kreiger, N., Gallinger, S., Tomlinson, G. & Cotterchio, M. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: Findings from the Canadian national enhanced cancer surveillance system. Ann. Epidemiol. 16, 908916 (2006).

PubMed Article Google Scholar

Fernandez, E. et al. Hormone replacement therapy and cancer risk: A systematic analysis from a network of casecontrol studies. Int. J. Cancer 105, 408412 (2003).

CAS PubMed Article Google Scholar

Grossman, D. C. et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force recommendation statement. JAMA 318, 22242233 (2017).

PubMed Article Google Scholar

Rymer, J., Brian, K. & Regan, L. HRT and breast cancer risk. BMJ 367, 25 (2019).

Google Scholar

Hamoda, H. & Moger, S. Looking at HRT in perspective. BMJ 377, o1425 (2022).

PubMed Article Google Scholar

Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the global burden of disease study. JAMA Oncol. 4, 15531568 (2018).

PubMed Article Google Scholar

Xu, C. Y. et al. Prognostic role of estrogen receptor and estrogen receptor in gastric cancer. Ann. Surg. Oncol. 17, 25032509 (2010).

CAS PubMed Article Google Scholar

Qin, J. et al. The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells. Mol. Cell. Biochem. 395, 99107 (2014).

CAS PubMed Article Google Scholar

Kim, M. J. et al. Effects of 17-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. J. Gastr. Cancer 13, 172178 (2013).

Article Google Scholar

Rahman, M. S. & Cao, J. Estrogen receptors in gastric cancer: Advances and perspectives. World J. Gastroenterol. 22, 24752482 (2016).

CAS PubMed Central Article Google Scholar

Chandanos, E. et al. Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur. J. Cancer 44, 10071014 (2008).

CAS PubMed Article Google Scholar

Visit link:
Association of hormone replacement therapy with risk of gastric cancer: a systematic review and meta-analysis | Scientific Reports - Nature.com

Comments are closed.